AVW-32268-79915
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 480 / MI
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tiredness, Diarrhea · Be unable to workAdult check-in
- 2020-12-27
- 2020-12-28
-
2020-12-29
Health check-in — day 7, dose 1Feeling: Poor · Fever · Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-29
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-26
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-17
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Call center
3 call center cases
1 successful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 10 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release